Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth

Lu-Lu Wang1, Hui-Hui Guo1, Yun Zhan1

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, People's Republic of China.

Oncotarget
|April 28, 2017
PubMed

Insights

Small active RNA (saRNA) p21-saRNA-322 boosts p21 gene expression to inhibit colorectal cancer growth. Studies show it induces apoptosis, cell cycle arrest, and reduces tumor growth in vivo.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Therapeutics

Background:

  • Down-regulation of p21 is a hallmark of colorectal cancer.
  • Small active RNA (saRNA) p21-saRNA-322 demonstrates potential for cancer therapy by stimulating p21 gene expression.
  • Colorectal cancer presents a viable target for in situ saRNA delivery.

Purpose of the Study:

  • To investigate the efficacy of p21-saRNA-322 in colorectal cancer models.
  • To evaluate the molecular mechanisms underlying p21-saRNA-322's anti-cancer effects.
  • To assess the in vivo tumor-suppressing capabilities of p21-saRNA-322.

Main Methods:

  • Transfection of human colorectal cancer cell lines (HCT-116, HCT-116 (p53-/-), HT-29) with p21-saRNA-322.
  • Measurement of p21 mRNA and protein expression via RT-PCR and Western blot.
  • In vitro assessment of cellular effects and in vivo evaluation using a xenograft colorectal tumor model in mice.

Main Results:

  • p21-saRNA-322 transfection significantly increased p21 mRNA and protein levels in all tested cell lines.
  • Treatment induced apoptosis, cell cycle arrest at G0/G1, reduced colony formation, and promoted senescence.
  • In vivo studies demonstrated significant inhibition of tumor growth and enhanced p21 activation in a mouse xenograft model.

Conclusions:

  • p21-saRNA-322 effectively up-regulates p21 expression in colorectal cancer cells.
  • The saRNA exhibits potent anti-proliferative and tumor-suppressing effects in vitro and in vivo.
  • p21-saRNA-322 represents a promising therapeutic strategy for colorectal cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K